Antonio Russo

Antonio Russo

Auto-generated profile, based on publicly available information

Antonio Russo

Heart Failure and Transplant Program Cardiology Unit IRCCS Azienda Ospedaliero‐Universitaria di Bologna Policlinico S Orsola‐Malpighi University of Bologna Bologna Italy

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2015 in Amyloid
Verified
Journal Article
Closed access
SLSimone Longhi
Simone Longhi
CQCandida Cristina Quarta
Candida Cristina Quarta
AMAgnese Milandri
Agnese Milandri
MLMassimiliano Lorenzini
Massimiliano Lorenzini
CGChristian Gagliardi
Christian Gagliardi
CRClaudio Rapezzi
Claudio Rapezzi
Although atrial fibrillation (AF) is a known complication of amyloidotic cardiomyopathy (AC), a precise pathophysiological and prognostic characterization is not available. We therefore aimed to assess prevalence, incidence, risk factors and prognostic significance of AF in light-chain (AL), hereditary transthyretin-related (m-ATTR) and non-mutant transthyretin-related (wt-ATTR) AC. Retrospective study of 262 patients with AC (123 AL, 94 m-ATTR, 45 wt-ATTR) from a single center. AF prevalence was 15% (AL 9%, m-ATTR 11%, wt-ATTR 40%). During a median follow-up of 1.2 years 11 patients developed AF (2.1% person-years). Age, heart failure (HF), left ventricular (LV) ejection fraction, renal involvement, left atrial size and right atrial pressure were independently associated with AF. AF was associated with incident HF but not with increased mortality. All AF patients were prescribed warfarin and none suffered thromboembolic events. In AC the prevalence of AF varies widely according to etiology with a mean value of 15% that reaches 40% in wt-ATTR amyloidosis. Age, HF, LV ejection fraction, left atrial size and right atrial pressure were the main independent risk factors, while wall thickness and etiology were not the main independent risk factors. AF does not seem to impact all-cause mortality but was strongly associated with prevalent and incident HF.


1 September 1992 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
ARAntonio Russo
Antonio Russo
Viviana BazanViviana Bazan
Viviana Bazan
SPSergio Plaja
Sergio Plaja
MCMassimo Cajozzo
Massimo Cajozzo
PBPietro Bazan
Pietro Bazan

1 January 2015 in Journal of Cardiovascular Ultrasound
Verified
Journal Article
Open access
PDF file
FGFrancesco Grigioni
Francesco Grigioni
ARAntonio Russo
Antonio Russo
FPFerdinando Pasquale
Ferdinando Pasquale
EBElena Biagini
Elena Biagini
FBFrancesco Barberini
Francesco Barberini
CRClaudio Rapezzi
Claudio Rapezzi
Grigioni F, et al. J Cardiovasc Ultrasound. 2015 Sep;23(3):121-133. http://dx.doi.org/10.4250/jcu.2015.23.3.121

1 April 2019 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
LPLuciano Potena
Luciano Potena
VAV. Agostini
V. Agostini
LBL. Borgese
L. Borgese
ERE. Rinaldi
E. Rinaldi
LGLaura Giovannini
Laura Giovannini
PHP. Halloran
P. Halloran

1 January 2011 in Archives of Cardiovascular Diseases Supplements
Verified
Journal Article
Closed access
TTThierry Le Tourneau
Thierry Le Tourneau
DMDavid Messika-Zeitoun
David Messika-Zeitoun
ARAntonio Russo
Antonio Russo
DDDelphine Detaint
Delphine Detaint
YTYan Topilsky
Yan Topilsky
MEMaurice Enriquez-Sarano
Maurice Enriquez-Sarano